Tags

Type your tag names separated by a space and hit enter

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma.
Emerg Microbes Infect. 2022 Dec; 11(1):424-427.EM

Authors+Show Affiliations

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People's Republic of China. Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People's Republic of China.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People's Republic of China. Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People's Republic of China.The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People's Republic of China. Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People's Republic of China.Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People's Republic of China.Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People's Republic of China.Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.

Pub Type(s)

Letter

Language

eng

PubMed ID

35001836

Citation

Wang, Yingdan, et al. "Resistance of SARS-CoV-2 Omicron Variant to Convalescent and CoronaVac Vaccine Plasma." Emerging Microbes & Infections, vol. 11, no. 1, 2022, pp. 424-427.
Wang Y, Ma Y, Xu Y, et al. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. Emerg Microbes Infect. 2022;11(1):424-427.
Wang, Y., Ma, Y., Xu, Y., Liu, J., Li, X., Chen, Y., Chen, Y., Xie, J., Xiao, L., Xiang, Z., Wu, F., & Huang, J. (2022). Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. Emerging Microbes & Infections, 11(1), 424-427. https://doi.org/10.1080/22221751.2022.2027219
Wang Y, et al. Resistance of SARS-CoV-2 Omicron Variant to Convalescent and CoronaVac Vaccine Plasma. Emerg Microbes Infect. 2022;11(1):424-427. PubMed PMID: 35001836.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. AU - Wang,Yingdan, AU - Ma,Yunping, AU - Xu,Yan, AU - Liu,Jiangyan, AU - Li,Xiang, AU - Chen,Yuyuan, AU - Chen,Yan, AU - Xie,Jun, AU - Xiao,Lianbo, AU - Xiang,Zheng, AU - Wu,Fan, AU - Huang,Jinghe, PY - 2022/1/11/pubmed PY - 2022/2/8/medline PY - 2022/1/10/entrez SP - 424 EP - 427 JF - Emerging microbes & infections JO - Emerg Microbes Infect VL - 11 IS - 1 SN - 2222-1751 UR - https://www.unboundmedicine.com/medline/citation/35001836/Resistance_of_SARS_CoV_2_Omicron_variant_to_convalescent_and_CoronaVac_vaccine_plasma_ L2 - https://www.tandfonline.com/doi/full/10.1080/22221751.2022.2027219 DB - PRIME DP - Unbound Medicine ER -